Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Mazindol CR by NLS Pharmaceutics for Opium (Opioid) Addiction: Likelihood of Approval
Mazindol CR is under clinical development by NLS Pharmaceutics and currently in Phase II for Opium (Opioid) Addiction. According to...